Sep 18, 2025: 7 new IQVIA profiles added from around the globe
Have a peek at our newly-profiled healthcare databases from Austria, Colombia, Japan, NZ, Rep of Korea, USA!
Have a peek at our newly-profiled healthcare databases from Austria, Colombia, Japan, NZ, Rep of Korea, USA!
Email: RWDassets@IQVIA.com
N/A
To find publications, please visit https://rwsbibliography.iqvia.com/ or contact IQVIA.
Email: RWDassets@IQVIA.com
N/A
To find publications, please visit https://rwsbibliography.iqvia.com/ or contact IQVIA.
Email: RWDassets@IQVIA.com
N/A
To find publications, please visit https://rwsbibliography.iqvia.com/ or contact IQVIA.
Email: RWDassets@iqvia.com
N/A
Publications are pending. Please contact IQVIA for more information.
Email: RWDassets@iqvia.com
N/A
Very new database; publications pending. However, you may contact IQVIA for more information.
Email: RWDassets@IQVIA.com
N/A
To get information on publications please contact IQVIA or visit https://rwsbibliography.iqvia.com/
Email: RWDassets@IQVIA.com
N/A
Ito T, Kamei K, Yuasa A, Matsumoto F, Hoshi Y, Okada M, Noto S. Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons. J Dermatol. 2022 Jun;49(6):584-593.
To get information on publications please contact IQVIA or visit https://rwsbibliography.iqvia.com/
Consider investing just $5,000 to let 10 people at your organization search and compare ~525 healthcare database profiles from 70+ countries to find the perfect database for your next project or study.
Benefits of subscription include the ability to:
With data starting in 2017, the International Severe Asthma Registry (ISAR) is the first global registry for severe asthma, created as a joint initiative where national registries retain ownership of their data while sharing it with ISAR for ethically approved research. By collecting anonymized, standardized patient-level data from around the world, ISAR provides a unique, longitudinal and real-life resource to study severe asthma.